SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-025920
Filing Date
2021-05-13
Accepted
2021-05-13 08:15:58
Documents
48
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_citiuspharma.htm 10-Q 457493
2 CERTIFICATION f10q0321ex31-1_citiuspharma.htm EX-31.1 12432
3 CERTIFICATION f10q0321ex31-2_citiuspharma.htm EX-31.2 12512
4 CERTIFICATION f10q0321ex32-1_citiuspharma.htm EX-32.1 6143
  Complete submission text file 0001213900-21-025920.txt   2725950

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ctxr-20210331.xml EX-101.INS 395998
6 XBRL SCHEMA FILE ctxr-20210331.xsd EX-101.SCH 51238
7 XBRL CALCULATION FILE ctxr-20210331_cal.xml EX-101.CAL 38501
8 XBRL DEFINITION FILE ctxr-20210331_def.xml EX-101.DEF 114267
9 XBRL LABEL FILE ctxr-20210331_lab.xml EX-101.LAB 286848
10 XBRL PRESENTATION FILE ctxr-20210331_pre.xml EX-101.PRE 200186
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 21917313
SIC: 2834 Pharmaceutical Preparations